Bacchus Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $50K

  • Investors
  • 3

Bacchus Therapeutics General Information

Description

Developer of targeted cancer therapies designed to exploit cancer's altered metabolic pathways for treatment purposes. The company creates small molecules that help shrink cancers linked to the MYC gene and uses a special testing method to quickly see if the treatment is working by measuring specific biomarkers, enabling patients and doctors to get answers faster.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 11100 Endeavor Court
  • Manassas, VA 20109
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 11100 Endeavor Court
  • Manassas, VA 20109
  • United States

Bacchus Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bacchus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Aug-2025 $50K Completed Startup
2. Accelerator/Incubator 10-Jun-2024 Completed Startup
1. Accelerator/Incubator 09-Jun-2020 Completed Startup
To view Bacchus Therapeutics’s complete valuation and funding history, request access »

Bacchus Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Virginia Innovation Partnership Corporation Not-For-Profit Venture Capital
Regional Accelerator & Mentoring Program Accelerator/Incubator
MBC BioLabs Accelerator/Incubator
To view Bacchus Therapeutics’s complete investors history, request access »

Bacchus Therapeutics FAQs

  • Where is Bacchus Therapeutics headquartered?

    Bacchus Therapeutics is headquartered in Manassas, VA.

  • What industry is Bacchus Therapeutics in?

    Bacchus Therapeutics’s primary industry is Drug Discovery.

  • Is Bacchus Therapeutics a private or public company?

    Bacchus Therapeutics is a Private company.

  • What is Bacchus Therapeutics’s current revenue?

    The current revenue for Bacchus Therapeutics is .

  • Who are Bacchus Therapeutics’s investors?

    Virginia Innovation Partnership Corporation, Regional Accelerator & Mentoring Program, and MBC BioLabs have invested in Bacchus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process